Literature DB >> 7061483

Evidence for two distinct forms of mammalian beta-mannosidase.

G Dawson.   

Abstract

Liver from goats with an inherited deficiency of beta-D-mannosidase appears only partially deficient in beta-mannosidase (40% of normal values) when assayed with synthetic beta-mannoside substrates at pH 5.0. Other tissues such as brain and cultured skin fibroblasts show an almost complete deficiency of beta-mannosidase activity. Fractionation of supernatant solutions of normal goat liver on columns of concanavalin A bound to Sepharose 4B resolved beta-mannosidase into a bound (acidic) form (pH optimum, 5.0 to 5.5) and an unbound (neutral) form (broad pH optimum from 5.0 to 8.0). Both forms were heat-labile, inhibited by sodium taurocholate (0.1%) and insensitive to divalent cations such as zinc. However, only the acid lysosomal) form was able to hydrolyze a Man beta GlcNAc beta [3H]GlcNAc trisaccharide. Comparable fractionation of liver from affected goats revealed normal levels of the unbound (neutral) form but a complete absence of the bound (acidic, lysosomal) form. Fractionation of liver from an obligate heterozygote goat revealed normal neutral and 50% of the acidic. These studies suggest that goat liver contains both lysosomal beta-mannosidase (acidic form; deficient in beta-mannosidosis) and nonlysosomal beta-mannosidase (neutral) activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Properties and prenatal ontogeny of beta-D-mannosidase in selected goat tissues.

Authors:  R D Pearce; J W Callahan; P B Little; D T Armstrong; D Kiehm; J T Clarke
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Co2+-mediated time- and temperature-dependent activation of neutral alpha-D-mannosidase from monkey brain.

Authors:  R Mathur; K Panneerselvam; A S Balasubramanian
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

3.  Animal model of human disease. Bovine beta-mannosidosis.

Authors:  M Z Jones; B Abbitt
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

4.  Reduced phospholipase activity, peptide storage and the pathogenesis of canine neuronal ceroid-lipofuscinosis.

Authors:  G Dawson; J Kilkus; A N Siakotos
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Possible beta-mannosidosis chimera. Altered expression of metabolic perturbations.

Authors:  M Z Jones; K T Cavanagh; R Kranich; C Traviss; Y Fujita; M Ohta; F Matsuura
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Partial purification of goat kidney beta-mannosidase.

Authors:  J I Frei; K T Cavanagh; R A Fisher; R P Hausinger; M Dupuis; E J Rathke; M Z Jones
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

7.  In vivo inhibition of beta-glucosidase and beta-mannosidase activity in rats by 2-deoxy-2-fluoro-beta-glycosyl fluorides and recovery of activity in vivo and in vitro.

Authors:  J D McCarter; M J Adam; N G Hartman; S G Withers
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

8.  beta-Mannosidase in human leukocytes and fibroblasts.

Authors:  R S Panday; O P van Diggelen; W J Kleijer; M F Niermeijer
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

9.  Caprine beta-D-mannosidosis: characterization of a model lysosomal storage disorder.

Authors:  R D Pearce; J W Callahan; P B Little; L R Klunder; J T Clarke
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

10.  Bovine kidney beta-mannosidase: purification and characterization.

Authors:  B L Sopher; C E Traviss; K T Cavanagh; M Z Jones; K H Friderici
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.